Facilitation of TRKB activation by the angiotensin II receptor type-2 (AT2R) agonist C21 (2021)
Fonte: Pharmaceuticals. Unidade: FMRP
Assuntos: ANGIOTENSINA II, SISTEMA RENINA-ANGIOTENSINA, RECEPTORES DE ANGIOTENSINA, ANTIDEPRESSIVOS, SISTEMA NERVOSO CENTRAL, HOMEOSTASE, ESTRESSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAUKKANEN, Liina et al. Facilitation of TRKB activation by the angiotensin II receptor type-2 (AT2R) agonist C21. Pharmaceuticals, v. 14, n. 8, p. 1-10, 2021Tradução . . Disponível em: https://doi.org/10.3390/ph14080773. Acesso em: 17 out. 2024.APA
Laukkanen, L., Diniz, C. R. A. F., Foulquier, S., Prickaerts, J., Castrén, E., & Casarotto, P. C. (2021). Facilitation of TRKB activation by the angiotensin II receptor type-2 (AT2R) agonist C21. Pharmaceuticals, 14( 8), 1-10. doi:10.3390/ph14080773NLM
Laukkanen L, Diniz CRAF, Foulquier S, Prickaerts J, Castrén E, Casarotto PC. Facilitation of TRKB activation by the angiotensin II receptor type-2 (AT2R) agonist C21 [Internet]. Pharmaceuticals. 2021 ; 14( 8): 1-10.[citado 2024 out. 17 ] Available from: https://doi.org/10.3390/ph14080773Vancouver
Laukkanen L, Diniz CRAF, Foulquier S, Prickaerts J, Castrén E, Casarotto PC. Facilitation of TRKB activation by the angiotensin II receptor type-2 (AT2R) agonist C21 [Internet]. Pharmaceuticals. 2021 ; 14( 8): 1-10.[citado 2024 out. 17 ] Available from: https://doi.org/10.3390/ph14080773